tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA
US Market

Innate Pharma (IPHA) Technical Analysis

Compare
109 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
0Neutral
9Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Innate Pharma’s (IPHA) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Innate Pharma is a Buy.
Innate Pharma’s (IPHA) 20-Day exponential moving average is 1.89, while Innate Pharma’s (IPHA) share price is $1.82, making it a Sell.
Innate Pharma’s (IPHA) 50-Day exponential moving average is 1.94, while Innate Pharma’s (IPHA) share price is $1.82, making it a Sell.

Innate Pharma (IPHA) Pivot Points

Apr 12, 2025, 02:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.55
1.67
1.72
1.84
1.89
2.01
2.06
Fibonacci
1.67
1.73
1.77
1.84
1.90
1.94
2.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma (IPHA) Moving Averages

Apr 12, 2025, 02:04 PM
Period
Simple
Exponential
MA5
1.80Buy
1.83Buy
MA10
1.82Buy
1.85Buy
MA20
1.90Sell
1.89Sell
MA50
1.99Sell
1.94Sell
MA100
1.89Sell
1.96Sell
MA200
2.00Sell
2.08Sell
Innate Pharma’s (IPHA) 10-Day exponential moving average is 1.85, while Innate Pharma’s (IPHA) share price is $1.82, making it a Buy.
Innate Pharma’s (IPHA) 100-Day exponential moving average is 1.96, while Innate Pharma’s (IPHA) share price is $1.82, making it a Sell.
Innate Pharma’s (IPHA) stock price is $1.82 and Innate Pharma’s (IPHA) 50-day simple moving average is 1.99, creating a Sell signal.
Innate Pharma’s (IPHA) stock price is $1.82 and Innate Pharma’s (IPHA) 100-day simple moving average is 1.89, creating a Sell signal.
Innate Pharma’s (IPHA) stock price is $1.82 and Innate Pharma’s (IPHA) 200-day simple moving average is 2.00, creating a Sell signal.

Innate Pharma (IPHA) Technical Indicators

Apr 12, 2025, 02:04 PM
Name
Value
Implied Action
RSI (14)
46.49
Neutral
STOCH (9,6)
42.86
Neutral
STOCHRSI (14)
39.73
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
17.73
Buy
Williams %R
-50.00
Buy
CCI (14)
-125.24
Buy
ATR (14)
0.13
-
Ultimate Oscillator
45.29
Neutral
ROC
-4.57
Sell
Innate Pharma’s (IPHA) Relative Strength Index (RSI) is 46.49, creating a Neutral signal.
Innate Pharma’s (IPHA) Trend Strength Indicator (ADX) is 17.73, creating a Buy signal.
Innate Pharma’s (IPHA) Commodity Channel Index (CCI) is -125.24, creating a Buy signal.
Innate Pharma’s (IPHA) Price Rate of Change (ROC) is -4.57, creating a Sell signal.

FAQ

Is IPHA a Buy, Hold, or Sell?
Based on IPHA’s technical indicators, IPHA is a Sell.
    What is IPHA’s RSI (14)?
    IPHA’s RSI (14) is 46.49, which suggests IPHA is a Neutral.
      What is IPHA’s MACD?
      IPHA’s MACD is -0.04, which suggests IPHA is a Buy.
        What is IPHA’s 5-day moving average?
        IPHA’s 5-day moving average is 1.80, which suggests IPHA is a Buy.
          What is IPHA’s 20-day moving average?
          IPHA 20-day moving average is 1.90, which suggests IPHA is a Sell.
            What is IPHA’s 50-day moving average?
            IPHA’s 50-day moving average is 1.99, which suggests IPHA is a Sell.
              What is IPHA’s 200-day moving average?
              IPHA’s 200-day moving average is 2.00, which suggests IPHA is a Sell.
                What is IPHA’s Williams % R (14)?
                IPHA’s Williams % R (14) is -50.00, which suggests IPHA is a Buy.
                  What is IPHA’s CCI (14)?
                  IPHA’s CCI (14) is -125.24, which suggests IPHA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis